The Forgotten Message From Gold: FVC Is a Primary Clinical Outcome Measure of Bronchodilator Reversibility in COPD

Pulmonary Pharmacology and Therapeutics- United States

doi 10.1016/j.pupt.2008.04.005

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

October 1, 2008

Authors

Christian Préfaut

Abdelkrim Zbidi

Publisher

Elsevier BV

Related search

Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV1/FVC

Respiratory Care

Respiratory Medicine

Intensive Care Medicine

English

Is “Personal Recovery” a Useful Measure of Clinical Outcome?

Psychiatric Services

English

Is Bronchodilator the Correct Treatment for COPD Subjects Before EBUS?

Journal of Thoracic Disease

Respiratory Medicine

English

Clinical and Airway Inflammation Features of COPD Patients With Positive Bronchodilator Test

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

English

In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials

English

The Role of Bronchodilator Treatment in the Prevention of Exacerbations of COPD

European Respiratory Journal

Respiratory Medicine

English

Comparative Efficacy of Combination Bronchodilator Therapies in COPD: A Network Meta-Analysis

International Journal of COPD

Respiratory Medicine

Occupational Health

English

Patient-Reported Outcomes of Dual Bronchodilator Fixed-Dose Combination Versus Bronchodilator Monotherapy in Individuals With COPD

International Journal of COPD

Respiratory Medicine

Occupational Health

English

Is in Hospital Mortality Following EVAR Still a Valid Outcome Measure?

European Journal of Vascular and Endovascular Surgery

Cardiovascular Medicine

English